State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150001, China.
Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan 48824.
J Biol Chem. 2019 Oct 18;294(42):15346-15357. doi: 10.1074/jbc.RA119.008450. Epub 2019 Aug 23.
The nuclear export receptor CRM1 is an important regulator involved in the shuttling of various cellular and viral RNAs between the nucleus and the cytoplasm. HIV-1 Rev interacts with CRM1 in the late phase of HIV-1 replication to promote nuclear export of unspliced and single spliced HIV-1 transcripts. However, other cellular factors involved in the CRM1-dependent viral RNA nuclear export remain largely unknown. Here, we demonstrate that ANP32A and ANP32B mediate the export of unspliced or partially spliced viral mRNA via interactions with Rev and CRM1. We found that a double, but not single, knockout of ANP32A and ANP32B significantly decreased the expression of gag protein. Reconstitution of either ANP32A or ANP32B restored the viral production equally. Disruption of both ANP32A and ANP32B expression led to a dramatic accumulation of unspliced viral mRNA in the nucleus. We further identified that ANP32A and ANP32B interact with both Rev and CRM1 to promote RNA transport. Our data strongly suggest that ANP32A and ANP32B play an important role in the Rev-CRM1 pathway, which is essential for HIV-1 replication, and our findings provide a candidate therapeutic target for host defense against retroviral infection.
核输出受体 CRM1 是一种重要的调节因子,参与各种细胞和病毒 RNA 在核和细胞质之间的穿梭。HIV-1 Rev 在 HIV-1 复制的晚期与 CRM1 相互作用,促进未剪接和单剪接 HIV-1 转录本的核输出。然而,其他参与 CRM1 依赖性病毒 RNA 核输出的细胞因子在很大程度上仍然未知。在这里,我们证明 ANP32A 和 ANP32B 通过与 Rev 和 CRM1 的相互作用介导未剪接或部分剪接的病毒 mRNA 的输出。我们发现,ANP32A 和 ANP32B 的双重而非单敲除显著降低了 gag 蛋白的表达。重组任何一种 ANP32A 或 ANP32B 均可等量恢复病毒产生。破坏 ANP32A 和 ANP32B 的表达均会导致未剪接的病毒 mRNA 在核内大量积累。我们进一步确定 ANP32A 和 ANP32B 与 Rev 和 CRM1 相互作用,以促进 RNA 转运。我们的数据强烈表明,ANP32A 和 ANP32B 在 Rev-CRM1 途径中发挥重要作用,该途径对于 HIV-1 复制至关重要,我们的发现为宿主防御逆转录病毒感染提供了一个候选治疗靶点。